王洋洋,陈楚,郑烈,马芳,李俏飞,闻新丽

• 1:陕西中医药大学
• 2:陕西省中医医院

摘要(Abstract)：

腹泻型肠易激综合征(IBS-D)系指以腹痛、腹泻等腹部不适症状为主的一种功能性肠病。研究表明，IBS-D的发生与肠道菌群失衡密切相关；与此同时，大量研究证实中药有效成分可通过改变肠道黏膜结构、加强肠道黏膜屏障、促进机体代谢等方式，改善肠道微生态环境，尤其在治疗IBS-D中作用显著。故本研究通过查阅临床资料并检索相关文献，总结单味中药、复方制剂和中药提取物以肠道菌群为靶点治疗IBS-D的疗效，为进一步临床研究提供参考依据。

关键词(KeyWords)： 腹泻型肠易激综合征;中药;肠道菌群;代谢产物;肠道微生态失衡;综述

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划“中医药现代化研究”专项(2018YFC1705402);; 陕西省中医药管理局科研项目(2019-ZZJC0010);; 陕西省中医医院博士启动基金教育培养计划(2022)

作者(Author): 王洋洋,陈楚,郑烈,马芳,李俏飞,闻新丽

参考文献(References)：

• [1]侯晓华.2020年中国肠易激综合征专家共识意见[J].中华消化杂志，2020,40(12):803-818.
• [2]Palsson OS,Whitehead W,Tornblom H,et al.Prevalence of romeⅣfunctional bowel disorders among adults in the united states,canada,and the united kingdom[J].Gastroenterology,2020,158(5):1262-1273.
• [3]康雪莹，许裕伟，吴月霞.等.中医复方治疗腹泻型肠易激综合征研究进展[J].临床医药文献电子杂志，2020,7(46):192-193.
• [4]丁姮月，孙宏文.肠道菌群与腹泻型肠易激综合征相关性的研究进展[J].中国微生态学杂志，2019,31(1):119-125.
• [5]Jiménez Avalos Jorge Armando,Arrevillaga Boni Gerardo,González López Lorena,et al.Classical methods and perspectives for manipulating the human gut microbial ecosystem[J].Critical Reviews in Food Science and Nutrition,2021,61(2）.
• [6]吴巧珑，涂云.乌梅丸治疗腹泻型肠易激综合征临床疗效评价[J].中医临床研究，2020,12(13):116-118.
• [7]郭抗萧，彭买姣，彭昕欣，等.七味白术散对菌群失调腹泻小鼠肠道细菌多样性的影响[J].微生物学通报，2018,45(7):1470-1478.
• [8]Zhuang X,Xiong L,Li L,et al.Alterations of gut microbiota in patients with irritable bowel syndrome:A systematic review and meta-analysis[J].J Gastroenterol Hepatol,2017,32(1):28-38.
• [9]弓三东，崔立红.粪菌移植在肠易激综合征中的研究进展[J].解放军医学院学报，2015,36(10):1006-1010.
• [10]Kassinen A,Krogius-Kurikka L,M?kivuokko H,et al.The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects[J].Gastroenterology,2007,133(1):24-33.
• [11]Hong G,Li Y,Yang M,et al.Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome:An explorative study[J].Neurogastroenterol Motil,2020,32(11):e13891.
• [12]Mortensen PB,Andersen JR,Arffmann S,et al.Short-chain fatty acids and the irritable bowel syndrome:the effect of wheat bran[J].Scand J Gastroenterol,1987,22(2):185-192.
• [13]Martin-Gallausiaux C,Marinelli L,Blottière HM,et al.SC-FA:mechanisms and functional importance in the gut[J].Proc Nutr Soc,2021(80):37-49.
• [14]Asano T,Tanaka KI,Tada A,et al.Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats:possible involvement of 5-HT2A receptor[J].Br J Pharmacol,2017(174):3370-3381.
• [15]Zeng H,Umar S,Rust B,et al.Secondary bile acids and short chain fatty acids in the colon:a focus on colonic microbiomex,Cell Proliferation,Inflammation,and Cancer[J].Int JMol Sci,2019,20(5):1214.
• [16]Treem WR,Ahsan N,Kastoff G,et al.Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome:in vitro studies of carbohydrate fermentation[J].JPediatr Gastroenterol Nutr,1996,23(3):280-286.
• [17]Sun Qinghua,Jia Qiong,Song Lijin,et al.Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome:A systematic review and meta-analysis[J].Medicine,2019,98(7):519-524.
• [18]Zhao L,Yang W,Chen Y,et al.A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome[J].J Clin Invest,2020,130(1):438-450.
• [19]Odunsi-Shiyanbade ST,Camilleri M,Mc Kinzie S,et al.Effects of chenodeoxycholate and a bile acid sequestrant,colesevelam,on intestinal transit and bowel function[J].Clin Gastroenterol Hepatol,2010,8(2):159-165.
• [20]Zheng L,Wen XL.Gut microbiota and inflammatory bowel disease:The current status and perspectives[J].World JClin Cases,2021,9(2):321-333.
• [21]鄢伟伦，王帅帅，任霞.白术对小鼠肠道菌群调节作用的实验研究[J].山东中医杂志，2011,30(6):417-419.
• [22]Xu N,Kan P,Yao X,et al.AstragalosideⅣreversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice[J].J Microbiol,2018,56(11):838-846.
• [23]Chen L,Tai WCS,Hsiao WLW,et al.Dietary saponins from four popular herbal tea exert prebiotic-like effects on gut microbiota in C57BL/6 mice[J].J Funct Foods,2015,17(1):892-902.
• [24]Li J,Zhang X,Cao L,et al.Three inulin-type fructans from codonopsis pilosula(Franch.)Nannf.Roots and their prebiotic activity on bifidobacterium longum[J].Molecules,2018,23(12):3123.
• [25]庄彦华，杨春辉，杨旭东，等.中药“神曲”对肠易激综合征患者肠道菌群的调节和临床疗效的研究[J].中国微生态学杂志，2005,17(1):41-43.
• [26]Liu C,Zhang C,Lv W,et al.Structural modulation of gut microbiota during alleviation of suckling piglets diarrhoea with herbal formula[J].Evid Based Complement Alternat Med,2017:8358151.
• [27]杜健，朴春浩.乌梅丸加减治疗腹泻型肠易激综合征的临床观察[J].黑龙江中医药，2017,46(5):16-18.
• [28]刘佳星，王彦礼，李彧，等.四神丸对腹泻型肠易激综合征大鼠肠道菌群影响的实验研究[J].药学学报，2019,54(4):670-677.
• [29]姚思杰，王栩芮，张明明.痛泻要方对肝郁脾虚型IBS-D患者的临床疗效及其机制[J].中国实验方剂学杂志，2020,26(12):107-113.
• [30]江月斐，劳绍贤，邝枣园，等.清热化湿复方对腹泻型肠易激综合征脾胃湿热证肠道微生态影响的初步研究[J].福建中医学院学报，2008,18(4):1-4.
• [31]连秋华，朱惠萍，梁国强，等.健脾合剂对脾虚腹泻型肠易激综合征小鼠肠道菌群的干预研究[J].世界科学技术-中医药现代化，2020,22(3):775-785.
• [32]Sun SS,Wang K,Ma K,et al.An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia,hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota[J].Chin J Nat Med,2019,17(1):3-14.
• [33]Tao JH,Duan JA,Jiang S,et al.Polysaccharides from chrysanthemum morifolium ramat ameliorate colitis rats by modulating the intestinal microbiota community[J].Oncotarget,2017,8(46):80790-80803.
• [34]张宇，沈宇，胡新俊，等.黄芪多糖对微生态调节作用的物质基础研究初探[J].中国微生态学杂志，2012,24(2):113-116.
• [35]刘亚丽，宋永贵，关志宇，等.白头翁皂苷类成分的肠道菌群降解动力学[J].中国实验方剂学杂志，2015,21(8):1-4.
• [36]刘艳艳，张凯，关家伟，等.人参皂苷对BALB/c小鼠肠道菌群的影响[J].现代生物医学进展，2015,15(6):1041-1045.
• [37]李丽，马文娟，贾琪，等.实时荧光定量PCR联合高通量测序分析杠柳毒苷与三七总皂苷配伍对大鼠肠道菌群的影响[J].现代药物与临床，2019,42(3):432-436.
• [38]唐岚，傅璐璐，沈丽婷，等.大鼠肠道菌群对三七总皂苷体外降解的研究[J].中草药，2018,49(2):396-399.
• [39]Sun H,Zhang P,Zhu Y,et al.Antioxidant and prebiotic activity of five peonidin-based anthocyanins extracted from purple sweet potato (Ipomoea batatas (L.) Lam.)[J].Sci Rep,2018,(8):5018.
• [40]Miao L,Gong Y,Li H,et al.Alterations in cecal microbiota and intestinal barrier function of laying hens fed on fluoride supplemented diets[J].Ecotoxicol Environ Saf,2020,(193):110372.